American Johnson & Johnson, the world's largest manufacturer of medical products, following the results of the first quarter, reported the decline in net profit by 14.2% in annual terms to 3 billion 749 million dollars. Adjusted earnings in the amount of $2.10 cents per share exceeded economists' forecast of 2 dollars 4 cents per share. Revenue figure of 20 billion 21 million dollars grew over the year by only 0.1%, while experts had predicted 19 billion 610 million dollars. During the earnings period, the pharmaceutical business increased sales by 4.1% to 10 billion 244 million dollars. At the same time, the medical equipment division recorded a decline in revenue by 4.6% to $6 billion 549 million. Revenue in the consumer goods division fell by 2.4% to $3 billion 318 million.